New BPA for turalio
Active Awarded Last action
- Contract number
- 36E79725A0010
- Awardee
-
Daiichi Sankyo, Inc. UEI YUKQY5G72Q29
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 72% complete
- IDV ceiling
- $80,206.95
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Daiichi Sankyo, Inc., doing business as Daiichi Pharmaceutical Corp, received a single-award Blanket Purchase Agreement from the Department of Veterans Affairs National Acquisition Center effective May 22, 2025, through May 21, 2027, with four optional one-year renewal periods. Valued at $80,206.95, this firm fixed-price contract is established under the General Services Administration Pharmaceuticals and Drugs Schedule (FSS-61-IB) and authorizes participating Veterans Integrated Service Networks 20 and 22 to place delivery orders for TURALIO (pexidartinib) on an as-needed basis. The BPA encompasses both 125 milligram and 200 milligram capsule formulations of TURALIO, a specialized pharmaceutical indicated for the treatment of tenosynovial giant cell tumor, a rare musculoskeletal condition affecting veteran populations. No socioeconomic set-asides were used in this procurement, and Daiichi Sankyo operates as the prime contractor with no documented subcontractor relationships.
The BPA structure provides VA medical centers within the designated Veterans Integrated Service Networks streamlined procurement authority to access TURALIO without requiring individual competitive solicitations for each purchase order, thereby enabling efficient supply chain management for this specialized medication. The contract incorporates Public Law pricing mechanisms established in 2026 and maintains predetermined pricing throughout the contract term, ensuring budgetary predictability while accommodating variable ordering volumes across participating healthcare facilities. This procurement vehicle supports the Department of Veterans Affairs' mission to deliver targeted healthcare solutions and represents a continuation of Daiichi Sankyo's sustained supplier relationship with the VA, as evidenced by prior delivery order awards ranging from approximately $7,600 to $208,500.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0010?
36E79725A0010 was awarded to Daiichi Sankyo, Inc. by National Acquisition Center (Headquarters) on May 22, 2025.
How much is contract 36E79725A0010 worth?
36E79725A0010's own ceiling is $80,207.
Who can order from contract 36E79725A0010?
36E79725A0010 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0010 under another contract?
Yes. 36E79725A0010 is a blanket purchase agreement under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0010 competed?
The extent of competition for 36E79725A0010 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV